BAY 87-2243, an inhibitor of HIF-1α - induced gene activation, showed promising anti-tumor efficacy in combination with anti-angiogenic therapy and irradiation in preclinical tumor models

被引:3
作者
Hess-Stumpp, Holger [1 ]
机构
[1] Bayer Pharma AG, Berlin, Germany
关键词
D O I
10.1158/1538-7445.AM2012-LB-244
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
LB-244
引用
收藏
页数:1
相关论文
empty
未找到相关数据